Ottawa, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The synthetic biology market size is predicted to increase from USD 16.35 billion in 2023 to approximately USD 148.93 billion by 2033, According to Precedence Research. The synthetic biology market is driven by the increasing R&D activities and advancements in technologies.
The U.S synthetic biology market size was USD 4.81 billion in 2023, calculated at USD 5.85 billion in 2024 and is expected to cross around USD 41.26 billion by 2033.
The synthetic biology market is expanding at a significant growth rate due to the wide applications of synthetic biology in medicine, manufacturing, and agriculture sectors. It involves the genetic alteration of organisms to give them new abilities to deal with some of the most pressing challenges, such as the production of valuable substances like medicines and fuels and the enhancement of environmental sensing.
Research in this field constructs DNA sequences in the presence of existing genes and novel ones, introducing genome editing techniques to make exact changes. Some examples that scientists produce using synthetic biology include microorganisms harnessed for bioremediation, rice modified to produce beta-carotene, and genetically modified yeast to make rose oil substitutes.
The Complete Study is Immediately Accessible | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/2862
Synthetic Biology Market Key Insights
- North America dominated the synthetic biology market with the highest market share of 39.8% in 2023.
- Asia Pacific is expected to grow at the fastest rate during the forecast period.
- By technology, the PCR technology segment has contributed more than 28% of market share in 2023.
- By technology, the genome editing technology segment is expected to grow at a significant rate during the forecast period.
- By product, the oligonucleotide/oligo pools and synthetic DNA segment has generated the biggest market share of 35.6% in 2023.
- By product, the enzymes segment is expected to witness significant growth during the forecast period.
- By application, the healthcare segment has contributed the highest market share of 57.7% in 2023.
- By end-use, the biotechnology and pharmaceutical companies segment has held a major market share of 52.1% in 2023.
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308
Synthetic Biology Market Revenue (US$ Billion), By Technology, 2022 and 2023
| Technology | 2022 | 2023 |
| PCR | 3.75 | 4.59 |
| NGS | 2.95 | 3.59 |
| Bioprocessing | 1.61 | 1.96 |
| Genome Editing | 2.41 | 2.96 |
| Others | 2.68 | 3.26 |
Synthetic Biology Market Revenue (US$ Billion), By Product, 2022 and 2023
| Product | 2022 | 2023 |
| Enzymes | 3.35 | 4.09 |
| Oligonucleotide/Oligo Pools and Synthetic DNA | 4.76 | 5.83 |
| Xeno-Nucleic Acids | 1.61 | 1.95 |
| Cloning Technologies Kits | 2.68 | 3.27 |
| Chassis Organism | 1.01 | 1.21 |
Synthetic Biology Market Revenue (US$ Billion), By Application, 2022 and 2023
| Application | 2022 | 2023 |
| Healthcare | 7.77 | 9.42 |
| Non-Healthcare | 5.63 | 6.92 |
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/2862
Synthetic Biology Market by Regional Outlook
North America led the market with the largest market share of 39.8% in 2023.
Synthetic biology has revolutionized the biotechnology field in North America, specifically in the U.S, using advanced principles of engineering and biotechnological techniques. Backed by investments in DNA sequencing and genome editing technologies, this field captured the largest market share.
Integrating these advances with computational tools such as artificial intelligence accelerates design and testing cycles in predictions toward the efficient modification of organisms. The major application of synthetic biology is in drug development. Researchers and scientists in the region collaborate with academic institutions, government departments, and private investors to bring new inventions to the market.
Personalized your customization here: https://www.precedenceresearch.com/customization/2862
The market in Asia Pacific is expected to grow at the fastest rate during the forecast period due to rising investments in the biotech industry. Many countries, including India, China, Japan, and Singapore, have promoted synthetic biology through supportive policies, research programs, funding, and government initiatives. Furthermore, the rapid expansion of the biotech industry and the rising advancements in genomics and biotechnology are expected to fuel the market in the region.
Synthetic Biology Market Report Coverage:
| Report Attribute | Key Statistics |
| Market Size in 2024 | USD 20.01 Billion |
| Market Size by 2033 | USD 148.93 Billion |
| Growth Rate from 2024 to 2033 | CAGR of 25% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Quantitative Units | Revenue/Size in USD Million/Billion and CAGR from 2024 to 2033 |
| Segments Covered | Technology, Product, Application, End-Use and Regions |
| By Technology | PCR Technology, NGS Technology, Bioprocessing Technology, Genome Editing Technology, Other Technologies |
| By Product | Enzymes, Oligonucleotide/Oligo Pools and Synthetic DNA, Xeno-Nucleic Acids, Cloning Technologies Kits, Chassis Organism |
| By Application | Healthcare and Non-healthcare |
| By End-Use | Academic and Government Research Institutes, Biotechnology and Pharmaceutical Companies and Others |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
| Country Scope | U.S., Canada, UK, Germany, France, Italy, Spain, Norway, Sweden, Denmark, Japan, China, India, Australia, South Korea, Thailand, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Synthetic Biology Market Segments Outlook:
Technology Outlook
The PCR technology segment led the synthetic biology market in 2023 owing to the increasing adoption of this technology in genomic research. PCR is a simple, efficient, fast, and highly sensitive technique that yields millions to billions of copies of the product of interest for sequencing and cloning. Since its discovery, PCR has found applications in genotyping, cloning, mutation detection, sequencing, microarrays, forensic science, and paternity testing.
The genome editing technology segment is expected to grow significantly during the forecast period.
Genome editing technology improves the precision of cell genome alteration, including integrating and regulating large fragments of gene clusters. Genome editing is more effective and saves time than other genetic alteration methods. One of the most popular examples of this technology is CRISPR-Cas9, which targets several genes simultaneously.
Product Outlook
The oligonucleotide segment dominated the market in 2023 due to its wide range of applications in genetic research and testing. This versatile molecule is essential for antisense oligonucleotides, small interfering RNA, DNA sequencing primers, and more to perform exact genetic manipulation and analysis.
- In April 2024, Asahi Kasei Bioprocess collaborated with Axolabs Therapeutics to build a cutting-edge oligonucleotide cGMP manufacturing facility in Berlin, Germany.
The enzymes segment is expected to witness significant growth during the forecast period.
Synthetic biology tools are used to engineer microbial enzymes for industrial uses. Modifications in performance and suitability are used in the context of large-scale industrial applications, food, beverages, pharmaceuticals, and biofuels and enzymes such as laccases, xylanases, inulinase, lipases, and amylases.
- In June 2024, Basecamp Research entered into a partnership with the Ferruz Laboratory at the Institute of Molecular Biology of Barcelona to reveal ZymCTRL ("enzyme control"), allowing users to create new enzyme sequences by inputting an enzyme identification code, specifying the desired activity.
Application Outlook
The healthcare segment dominated the market in 2023 owing to the increasing genomic research. Synthetic biology (SynBio) has several applications in synthesizing enzymes, generating sustainable biofuels, and producing bio-based specialty products. SynBio supports rational drug design, cancer immunotherapy, and sustainability in medical practice.
In blood cancer research, breakthroughs include the development of Car-T therapy against lymphoma, which works by applying techniques of SynBio in modifying a patient’s immune system to replace the traditional chemotherapy against illnesses like Acute Lymphoblastic Leukemia.
End Use Outlook
The biotechnology and pharmaceutical companies segment dominated the market in 2023.
Synthetic biology is one of the methods of integration of heterologous pathways in designer cells, paving the way for efficient medical agent production and the optimization of natural product yields. It has become very important in medical research to generate genetic circuits targeting tumors and develop controllable release systems for therapeutic agents. It also targets highly complex immune diseases, infectious diseases, and metabolic disorders challenging conventional treatment methodologies.
- In June 2024, Cyrus Biotechnology is launching a business that is projected to expand access to the software technology of the company, with the potential of supporting innovation in drug development, agriculture, synthetic biology and manufacturing.
Browse More Insights:
- Structural Biology Market: The global structural biology market is surging, with an overall revenue growth expectation of hundreds of millions of dollars during the forecast period.
- Generative AI In Biology Market: The global generative AI in biology market size was estimated at USD 74 million in 2022 and it is projected to reach around USD 363.37 million by 2032, growing at a CAGR of 17.3%.
- Molecular Biology Enzymes Market: The global molecular biology enzymes market size was estimated at USD 17.95 billion in 2023 and is projected to hit around USD 65.63 billion by 2033, registering a CAGR of 13.86% from 2024 to 2033.
- Digital Genome Market: The global digital genome market size was valued at USD 42.23 billion in 2023 and is expected to be worth around USD 109.74 billion by 2033, growing at a CAGR of 10.20% from 2024 to 2033.
- Viral Vectors & Plasmid DNA Manufacturing Market: The global viral vectors & plasmid DNA manufacturing market size calculated at USD 6.26 billion in 2024 and is projected to grow around USD 23.7 billion by 2033, growing at a CAGR of 15.94% from 2024 to 2033.
- Plasmid DNA Manufacturing Market: The global plasmid DNA manufacturing market size was valued at USD 1.8 billion in 2023 and is anticipated to reach around USD 10.22 billion by 2033, growing at a CAGR of 18.73% from 2024 to 2033.
- Recombinant DNA Technology Market: The global recombinant DNA technology market size accounted for USD 856.81 billion in 2024 and is expected to reach around USD 1,623.52 billion by 2034, expanding at a CAGR of 6.6% from 2024 to 2034.
- U.S. Plasmid DNA Manufacturing Market: The U.S. plasmid DNA manufacturing market size was valued at USD 550 million in 2023 and is expected to be worth around USD 3,270 million by 2033, growing at a CAGR of 19.26% from 2024 to 2033.
Market Dynamics
Driver: Lesser wildlife exploitation
Synthetic biology has many applications in modern life, and some of them are related to conservation. It can provide alternatives to conventional products derived from wildlife, thereby reducing the demand for wildlife goods.
A synthetic substitute for horseshoe crab blood, an important biomedical commodity, has been developed that could minimize or totally remove the need to harvest endangered crabs. This development addresses conservation concerns and spurs the growth of the synthetic biology market.
Restraint: Safety and security concerns
Synthetic biology poses a serious threat to national security if it is used for nefarious purposes, such as producing new biological or chemical weapons.
Furthermore, computational tools utilized for synthetic biology are vulnerable to a variety of cyber threats, including automation hacking, through which bad actors might modify or steal information and potentially create dangerous products like drugs or weapons.
Opportunity: Rising area of applications
Research in synthetic biology is underway with respect to its potential applications in medicine, particularly in vaccine development. Optimizing the design of key molecules in synthetic biology helps to create vaccines against all viruses and their variants.
Synthetic biology can be used to enhance the process of drug discovery and development by employing AI and machine learning to screen DNA sequences for drug candidates at faster rates.
Synthetic Biology Market Key Players
- Codexis, Inc.
- Creative Enzymes.
- Creative Biogene.
- Merck Kgaa (Sigma-Aldrich Co. Llc)
- Pareto Bio, Inc.
- Illumina, Inc.
- Bota Biosciences Inc.
- Enbiotix, Inc.
- Scarab Genomics, Llc
- Synthetic Genomics Inc.
- New England Biolabs
- Novozymes
- Euro fins Scientific
- Synthego
- Thermo Fisher Scientific, Inc.
Recent Developments:
- In May 2024, Sojitz Corporation and Ginkgo Bioworks signed an agreement to build connections with businesses in Japan and encourage the adoption of synthetic biology to develop sustainable production processes.
- In March 2024, Pearl Bio collaborated with Merck to create biologic treatments through non-standard amino acids as part of a huge synthetic biology effort to increase the genetic code.
- In February 2024, NIST and EBRC entered into a strategic partnership to develop screening and safety tools to prevent misuse of AI related to nucleic acid synthesis.
- In July 2023, WPI researcher Eric Young and Kevin Keating have engineered a way in synthetic biology to express genes across a wide variety of bacterial species using a generalized collection of DNA parts.
Market Segmentation
By Technology
- PCR Technology
- NGS Technology
- Bioprocessing Technology
- Genome Editing Technology
- Other Technologies
By Product
- Enzymes
- Oligonucleotide/Oligo Pools and Synthetic DNA
- Xeno-Nucleic Acids
- Cloning Technologies Kits
- Chassis Organism
By Application
- Healthcare
- Non-Clinical
- Clinical
- Non-healthcare
- Specialty Chemicals
- Biotech Crops
- Bio-fuels
- Others
By End-Use
- Academic and Government Research Institutes
- Biotechnology and Pharmaceutical Companies
- Others
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/2862
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308
Unlocking Market Insights through Data Excellence
The "Precedence Statistics" flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today's dynamic and data-driven world.
To Access our Premium Real-Time Data Intelligence Tool, Visit: http://www.precedencestatistics.com
About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Web: https://www.precedenceresearch.com
Our Blogs:
https://www.towardshealthcare.com
https://www.towardspackaging.com
https://www.towardsautomotive.com
For Latest Update Follow Us:
